Τίτλος:
An open-label, randomised phase 3 study of daratumumab, lenalidomide, and dexamethasone (DRd) versus lenalidomide and dexamethasone (Rd) in relapsed or refractory multiple myeloma (RRMM): POLLUX
Συγγραφείς:
Dimopoulos, M
Oriol, A
Nahi, H
San Miguel, J
Bahlis, N
Rabin, N
Orlowski, R
Komarnicki, M
Suzuki, K
Plesner, T
others